MANGOCEUTICALS, INC. - MGRX

Sector: Healthcare · Industry: Health Information Services
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$444K
QoQ value delta ($000)
-$4K (-0.89%)
Implied price effect (QoQ)
+0.18%
Shares
Total shares
1,187,986
QoQ shares delta
-12,818 (-1.07%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (MGRX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 2 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
CITADEL ADVISORS LLC 128 338,964 0.0%
XTX Topco Ltd 70 186,256 0.0%
GEODE CAPITAL MANAGEMENT, LLC 59 156,243 0.0%
Ikarian Capital, LLC 52 138,146 0.01%
VANGUARD CAPITAL MANAGEMENT LLC 46 123,041 0.0%
VANGUARD FIDUCIARY TRUST CO 21 57,163 0.0%
NORTHERN TRUST CORP 14 37,579 0.0%
BOOTHBAY FUND MANAGEMENT, LLC 14 38,441 0.0%
HRT FINANCIAL LP 13 36,003 0.0%
Ackerman Capital Advisors, LLC 13 34,500 0.0%
ACT Advisors, LLC. 5 12,314 0.0%
GOLDMAN SACHS GROUP INC 4 11,589 0.0%
Csenge Advisory Group 3 10,000 0.0%
Fortitude Family Office, LLC 1 3,074 0.0%
AMERIFLEX GROUP, INC. 1 2,885 0.0%
BARCLAYS PLC 0 5 0.0%
MORGAN STANLEY 0 1,000 0.0%
Tower Research Capital LLC (TRC) 0 783 0.0%